Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 84, Issue 6, 1999, Pages 671-676

  Kawai, Keisuke ^b   Takaoka, Hideyuki ^a   Hata, Katsuya ^b   Yokota, Yoshiyuki ^b   Yokoyama, Mitsuhiro ^b  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; ASTHMA; BRADYCARDIA; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART VENTRICLE REMODELING; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOTENSION; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; VERTIGO;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CARDIAC VOLUME; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0033568629     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00414-2     Document Type: Article

References (30)

1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomized trial . Lancet. 353:1999;9-13.
2. Bristow M.R., Gilbert E.M., Abraham W.T., Adams K.F., Fowler M.B., Hershberger R.E., Kubo S.H., Narahara K.A., Ingersoll H., Krueger S., Young S., Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 94:1996;2807-2816.
3. Packer M., Colucci W.S., Sackner-Bernstein J.D., Liang C., Goldscher D.A., Freeman I., Kukin M.L., Kinhal V., Udelson J.E., Klapholz M., et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Circulation. 94:1996;2793-2799.
4. Waagstein F., Bristow M.R., Swedberg K., Camerini F., Fowler M.B., Silver M.A., Gilbert E.M., Johnson M.R., Goss F.G., Hjalmarson Å. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 342:1993;1441-1446.
5. Pinamonti B., Zecchin M., Lenarda A., Gregori D., Sinagra G., Camerini F. Persistence of restrictive lift ventricular filling pattern in dilated cardiomyopathy an ominous prognostic sign . J Am Coll Cardiol. 29:1997;604-612.
6. Steimle A.E., Stevenson L.W., Fonarow G.C., Hamilton M.A., Moriguchi J.D. Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol. 23:1994;553-559.
7. Hall S.A., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., Eichhorn E.J. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 25:1995;1154-1161.
8. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., Nordet P. Report of 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 93:1996;841-842.
9. Sellers R.D., Levy M.J., Amplatz K., Lillehei C.W. Left retrograde cardioangiography in acquired cardiac disease technic, indications and interpretations in 700 cases . Am J Cardiol. 14:1964;437-447.
10. Sekiguchi M, Hiroe M, Morimoto S. On the standardization of histopathological diagnosis and semiquantitative assessment of the endo-myocardium obtained by endomyocardial biopsy. Bull Heart Inst Japan 1979/80;21:55-85.
11. Sahn D.J., Demaria A., Kisslo J., Weyman A. The committee on M mode standardization of the American Society of Echocardiography recommendations regarding quantification in M mode echocardiography: results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
12. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 55:1977;613-618.
13. Shite J., Yokota Y., Yokoyama M. Heterogeneity and time course of improvement in cardiac function after cardioversion of chronic atrial fibrillation assessment of serial echocardiographic indices . Br Heart J. 70:1993;154-159.
14. Eichhorn E.J., Heesch C.M., Risser R.C., Marcoux L., Hatfield B. Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol. J Am Coll Cardiol. 25:1995;154-162.
15. Sinagra G., Rakar S., Zecchin M., Bussani R., Silvestri F., Bassan F., Gregori D., Perkan A., Lenarda A.D., Secoli G., Lardieri G., Camerini F. Nonpredictive value of fibrosis in dilated cardiomyopathy treated with metoprolol. Cardiovasc Pathol. 5:1996;21-28.
16. Shen W.F., Tribouilloy C., Rey J.L., Baudhuin J.J., Boey S., Dufosse H., Lesbre J.P. Prognostic significance of Doppler-derived left ventricular diastolic filling variables in dilated cardiomyopathy. Am Heart J. 124:1992;1524-1533.
17. Figulla H.R., Rahlf G., Nieger M., Luig H., Kreuzer H. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation. 71:1985;1095-1104.
18. Yamada T., Fukunami M., Omori M., Iwakura K., Kumagai K., Kondoh N., Minamino T., Tsujimura E., Nagareda T., Kotoh K., Hoki N. Which subgroup of patients with dilated cardiomyopathy would benefit from long term beta-blocker therapy? A histologic viewpoint. J Am Coll Cardiol. 21:1993;628-633.
19. Baandrup U., Florio R.A., Rehahn M., Richardson P.J., Olsen E.G.J. Clinical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. II Comparison of histology and clinical/hemodynamic information . Br Heart J. 45:1981;487-493.
20. Schwarz F., Mall G., Zebe H., Blickle J., Derks H., Manthey J., Kübler W. Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol. 51:1983;501-506.
21. Pinamonti B., Lenarda A.D., Sinagra G., Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by doppler echocardiography clinical, echocardiographic and hemodynamic correlations and prognostic implications . J Am Coll Cardiol. 22:1993;808-815.
22. Pozzoli M., Traversi E., Cioffi G., Stenner R., Sanarico M., Tavazzi L. Loading manipulations improve the prognostic value of doppler evaluation of mitral flow in patients with chronic heart failure. Circulation. 95:1997;1222-1230.
23. Xie G.Y., Berk M.R., Smith M.D., Gurley J.C., Demaria A.N. Prognostic value of doppler tranamitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 24:1994;132-139.
24. Andersson B., Caidahl K., Lenarda A.D., Warren S.E., Goss F., Waldenström A., Persson S., Wallentin I., Hjalmarson Å., Waagstein F. Changes in early and late diastolic filling patterns induced by long-term adrenergic β-blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 94:1996;673-682.
25. Lechat P., Escolano S., Golmard J.L., Lardoux H., Witchitz S., Henneman J.A., Maisch B., Hentzel M., Jaillon P., Boissel J.-P., Mallet A. Prognostic value of Bisoprolol-induced hemodynamic effects in heart failure during the cardiac insufficiency Bisoprolol study (CIBIS). Circulation. 96:1997;2197-2205.
26. Eichhorn E.J., Bristow M.R. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 94:1996;2285-2296.
27. Doherty N.E., Seelos K.C., Suzuki J., Caputo G.R., O'Sullivan M., Sobol S.M., Cavero P., Chatterjee K., Parmley W.W., Higgins C.B. Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J Am Coll Cardiol. 19:1992;1294-1302.
28. Greenberg B., Quinones M.A., Koilpillai C., Limacher M., Shindler D., Benedict C., Shelton B. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation. 91:1995;2573-2581.
29. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., Ohnishi M., Sugimoto Y., Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516.
30. Suwa M., Otake Y., Moriguchi A., Ito T., Hirota Y., Kawamura K., Adachi I., Nakabayashi I. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy. Am Heart J. 133:1997;353-358.